The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average
Related News
FDA approves remdesivir, first COVID-19 drug
In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in...
Chicago Sun-Times 2020-10-22FDA approves remdesivir, the first drug for treating COVID-19
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV. The drug, which...
The Post and Courier
2020-10-22
FDA approves Gilead's antiviral drug remdesivir to treat COVID-19
(NEXSTAR) – The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing...
Fox31 Denver
2020-10-23
Remdesivir Approved By FDA As First COVID-19 Treatment Drug
SACRAMENTO (AP/CBS13) – Remdesivir, an antiviral medicine given to hospitalized patients through an IV, was approved by U.S. regulators on Thursday as the first drug to...
CBS Sports 2020-10-23The FDA Approves The Anti-Viral Remdesivir As Its First Covid-19 Treatment Drug
According to a recent report from the Associated Press, U.S. regulators approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized...
The Source 2020-10-23